An analysis of tumor-infiltrated cells and lymphoid organs revealed the presence of enhanced cytotoxic CD8 T cell activity and reduced CD11b+Gr1+ myeloid cells in Il17d−/− mice upon tumor challenge (Figures 4D,E). This evidence concerns the gene CD8A and neoplasm.